CLINICAL_TRIALS
trial_result
· 2021-02-18
Clinical Trial Update: Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)
Summary
Clinical trial update reporting outcomes assessment for Parkinson's disease patients treated with XADAGO (safinamide).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Idiopathic Parkinson Disease | Status: COMPLETED | Results posted: 2021-02-18